|

Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval

RECRUITINGN/ASponsored by Asan Medical Center
Actively Recruiting
PhaseN/A
SponsorAsan Medical Center
Started2025-05-02
Est. completion2029-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to compare two pacemaker strategies: Left Bundle Branch Area Pacing (LBBAP) and Minimized Ventricular Pacing (MVP) in patients requiring a permanent pacemaker for sick sinus syndrome and prolonged AV interval. It will also evaluate the safety and feasibility of the LBBAP method in these patients. The main questions it aims to answer is: \*Is LBBAP with physiological AV interval better than Minimized Ventricular Pacing? Researchers will compare the LBBAP group (aiming for conduction system capture with physiological AV intervals) to the MVP group (aiming to minimize ventricular pacing with prolonged AV intervals) to evaluate the optimal pacing strategy. Participants will: * Be randomly assigned to either the LBBAP group or the MVP group. * Undergo a pacemaker implantation procedure according to the specific criteria for their assigned group. * Visit the clinic for regular checkups to measure pacing function and ensure the device settings remain compliant with the study protocol.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \>18 years old
* Sinus node dysfunction with symptoms
* Atrioventricular conduction delay (PR interval \> 200ms)

Exclusion Criteria:

* Subject was unable to provide written informed consent or participate in long-term follow-up.
* Permanent atrial fibrillation
* Pre-existing cardiac implantable electronic device
* Persistent advanced atrioventricular conduction disturbance (2:1 block, Mobitz type II, or 3rd degree)
* Mechanical tricuspid valve
* Ventricular septal defect or scar
* Left ventricular ejection fraction \< 35% who indicated cardiac resynchronization therapy
* Previous heart transplantation
* Pregnant and/or lactating women
* Life expectancy \<2 year
* Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period

Conditions3

Atrioventricular Nodal DysfunctionHeart DiseaseSick Sinus Syndrome

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.